04-May-17 As populations age and workforces decline, Southeast Asia is counting on high-tech remedies to turn back the clock. Large hospital operators are working with IBM to leverage AI and IoT to enhance patient outcomes, for example. [image: United Nations Economic and Social Commission for Asia and the Pacific]

20-Apr-17 The improving medical infrastructure across Asia has seen new destinations of choice emerge for tourists seeking treatments. Meanwhile, more hospitality players are entering into medical tourism to provide a holistic wellness experience. Asian resorts are seeing good therapy in linking up with hospitals to provide medical packages, enabling travellers to receive holistic treatments while on holidays. [image: TTG Asia]

06-Apr-17 In Japanese companies' largest study to date, Takeda will test an experimental dengue vaccine on 20,100 children and adolescents in eight countries in Latin America. Takeda said it has completed enrollment for a 20,000-subject dengue vaccine trial, the largest clinical study in its history, signalling the global ambitions of its vaccine business. [image: ET Healthworld]

17-Mar-17 TPG, the US alternative-investment firm, sees opportunities in healthcare in Asia to meet untapped demand in some of the fastest-growing economies. The region is short of quality healthcare infrastructure, said Jim Coulter, co-CEO. TPG’s Asian investment arm manages USD6 bn in assets, including a stake in the United Family Healthcare chain of high-end Chinese hospitals. [image: Bloomberg]

10-Feb-17 Carl Zeiss Meditec reported a 6.6% increase in revenue to €280 million in the first quarter of its 2016-2017 fiscal year, compared with €262.2 million in the same quarter a year ago. In the Asia-Pacific region, revenue increased 26.6% from €83.6 million to €105.8 million, attributed to the Chinese market and Southeast Asia and India. [image: Carl Zeiss]